Native and oxidized low density lipoproteins modulate mesangial cell apoptosis

Kidney International

Volumn 50, Issue 5, 1996, Pages 1604-1611

  Sharma, Pratima ^b   Reddy, Krishna ^b   Franki, Nicholas ^b   Sanwal, Vibha ^b   Sankaran, Ramkumar ^b   Ahuja, Tejinder S ^b   Gibbons, Nora ^b   Mattana, Joseph ^b   Singhal, Pravin C ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029907868     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.476     Document Type: Article

References (28)

1. SCHMITZ PG, KASISKE BL, O'DONNEL MP, KEANE WF: Lipids and progressive renal injury. Semin Nephrol 9:354-369, 1989
2. MOORHEAD JF, WHEELER DC, VARGHESE Z: Glomerular structure and lipids in progressive renal disease. Am J Med 87:12-20, 1989
3. KEANE WF, MULCHAY WS, KASISKE BL, KIM Y, O'DONNEL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl 31):S41-S48, 1991
4. AL-SHEBEB T, FROLICH JIR, MAGIL AB: Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study. Kidney Int 33:498-507, 1988
5. GRONE H, WALLI A, GRONE E, NIEDMANN P, THEIRY J, SEIDEL D, HELMCHEN U: Induction of glomerulosclerosis by dietary lipids, functional and morphological study in the rat. Lab Invest 60:433-445, 1989
6. KASISKE BL, O'DONNEL MP, GARNIS WJ, KEANE WF: Pharmacological treatment of hyperlipidemia decreases glomerular injury in 5/6 nephrectomy model of chronic renal failure. Circ Res 62:367-374, 1988
7. KASISKE BL, O'DONNEL MP, CLEARY MP, KEANE WF: Treatment of hyperlipidemia decreases glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
8. HARRIS KPG, PURKERSON ML, YATES J, KLAHR S: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 15:16-26, 1990
9. NEUGARTEN J, SCHLONDORFF D: Lipoprotein interaction with glomerular cells and matrix, in Contemp Issues Nephrol 24:173-206, 1991
10. WASSERMAN J, SANTIAGO A, RIFICI V, SCHLONDORFF D: Interaction of low density lipoprotein with rat mesangial cells. Kidney Int 35:1168-1174, 1989
11. GUPTA S, RIFICI V, CROWLEY S, BROWNLEE M, SHAN Z, SCHLONDROFF D: Interaction of low density lipoprotein and modified low density lipoprotein with mesangial cells and matrix. Kidney Int 41: 1161-1169, 1991
12. OREKHOV AN, TERTOV VV, KUDRYASHOV SA, SMIRNOV VN: Trigger like stimulation of cholesterol accumulation and DNA and extra cellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells. Circ Res 66:311-320, 1990
13. KIM SB, PARK S, SONG KY: Effects of LDL on type IV collagen production by cultured rat mesangial cells. (abstract) J Am Soc Nephrol 3:635, 1992
14. ROVIN BH, TAN LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225, 1993
15. CORSITIDS GV, RIFICI V, GUPTA S, SCHLONDORFF D: Preferential binding of LDL to rat glomerulus in vivo and cultured mesangial cells in vitro. Kidney Int 39:858-866, 1991
16. WHEELER DC, PERSUAD JW, FERNANDO R, SWENY P, VERGHESE Z, MOORHEAD JF: Effect of LDL on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 5:185-191, 1990
17. KEANE WF, O'DONNEL MP, KASISKE BL, KIM Y: Oxidative modification of LDL by mesangial cells. J Am Soc Nephrol 4:189-194, 1993
18. SINGHAL PC, SAGAR S, CHANDRA D, GARG P: Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity. Am J Pathol 147:25-32, 1995
19. SINGHAL PC, SHARMA P, GARG P: HIV-1 gp160 protein-macrophage interactions modulate mesangial cell proliferation and matrix synthesis. Am J Pathol 147:1780-1789, 1995
20. 2 analogue on uptake of IgG complexes and LDL by mesangial cells. Am J Physiol 261:F537-F544, 1991
21. BRADFORD M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
22. KOSUGI K, MOREL DW, DICORLETO PE, CHRISOLIN GM: Toxicity of oxidized LDL to cultured fibroblast is selective for S-phase of cell cycle. J Cell Physiol 130:311-320, 1987
23. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVIL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin invest 94:2105-2116, 1994
24. 1 macrophages exposed to oxidized LDL. FEBS Lett 332:218-220, 1993
25. GUENTTE RS, MOOIBROEK M, WONG K, WONG P, TENNISWOOD M: Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur J Biochem 226:311-321, 1994
26. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidine thiocyanate phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
27. LATTA H, FLIGIEL S: Mesangial fenestrations, sieving, filtration and flow. Lab Invest 52:591-598, 1985
28. DIAMOND JR, KARNOVSKY MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 33:671-678, 1987